Log in or Sign up for Free to view tailored content for your specialty!
Gynecologic Cancer News
Rutgers Cancer Institute of New Jersey appoints immunotherapy chief
Christian Hinrichs, MD, has been appointed chief of the section of cancer immunotherapy at Rutgers Cancer Institute of New Jersey.
Older women with ovarian cancer may benefit from more aggressive treatment
Upfront cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy may be a viable treatment for certain older women with ovarian cancer, according to results of a study published in Annals of Surgical Oncology.
Log in or Sign up for Free to view tailored content for your specialty!
Roswell Park Comprehensive Cancer Center announces appointments, promotions
Roswell Park Comprehensive Cancer Center announced the hiring or promotion of several people across clinical, administrative and research departments.
US cancer mortality continues to decline at record pace
Overall cancer mortality in the U.S. decreased by 31% between 1991 and 2018 amid continued advances in lung cancer treatment, according to American Cancer Society’s 70th annual report on cancer statistics.
FDA grants fast track designation to zenocutuzumab for neuregulin 1 fusion cancers
The FDA granted fast track designation to zenocutuzumab for treatment of patients with metastatic solid tumors that harbor neuregulin 1 fusion cancers that progressed on standard therapy.
City of Hope vice chair invited to join fellowship class
Lorna Rodriguez-Rodriguez, MD, PhD, has been invited to join The Carol Emmott Fellowship Class of 2021.
FDA updates safety guidance, labeling requirements for power morcellators
The FDA today issued a safety communication for patients and their health care providers that stresses the importance of shared decision-making regarding use of laparoscopic power morcellators during gynecologic surgeries.
Combination extends OS in advanced endometrial cancer
Pembrolizumab plus lenvatinib improved outcomes compared with chemotherapy for women with advanced endometrial cancer, according to topline data released by the agents’ manufacturers.
Obesity-associated cancers: An emergent problem among younger adults
The increasing prevalence and troubling consequences of obesity in the United States have been well-documented.
Studies show feasibility, potential of cascade testing for cancer-associated pathogenic variants
Melissa K. Frey, MD, does not believe a woman who has just been diagnosed with ovarian cancer should be responsible for telling her relatives they also may be at risk.